Women's Health and Chronic Conditions: 5 Things Ayurveda and Modern Science Actually Agree On

This article examines five specific, evidence-checkable points of agreement between Ayurvedic medicine and modern biomedical science in the treatment of chronic women's health conditions, distinguishing genuine convergence from forced or decorative comparison. It reviews polycystic ovary syndrome (PCOS) as described by the 2023 international evidence-based guideline (Teede et al., Journal of Clinical Endocrinology and Metabolism, developed through 52 systematic reviews and approved by Australia's National Health and Medical Research Council) against the classical Ayurvedic description of Artavavaha Srotas disorder in texts including the Astanga Hrdayam, alongside a 2023 scoping review identifying 57 published Ayurvedic studies on PCOS, including 13 randomized controlled trials. It examines curcumin's tested clinical role in PCOS-related insulin resistance and primary dysmenorrhea, citing specific randomized controlled trials with exact dosages and named mechanisms (NF-κB and COX-2 inflammatory pathway modulation). It reviews Withania somnifera (ashwagandha) research on hypothalamic-pituitary-adrenal (HPA) axis and GABAergic modulation relevant to PCOS and premenstrual syndrome. It examines a 2022 peer-reviewed call for transdisciplinary, convergent menopause research combining Ayurveda, Yoga, and biomedical science. The article concludes with an honest accounting of where this convergence is well-supported and where the clinical evidence remains genuinely mixed or preliminary.